Concept to Clinics
Lextro Bio Solutions offers integrated drug discovery solutions from Concept to Clinics in multiple therapeutic areas such as immune oncology, autoimmune diseases and metabolic disorders. Our experienced scientists, program managers, statutory bodies combined with our state-of-the-art infrastructure, aid in designing and conducting studies meticulously such that the journey from Concept to Clinics is rapid, qualitative and rewarding to our customers and collaborators.
Therapeutic selection
Competitive
Intelligence
Market
Evaluation
Feasibility report
TPP
Identification
of binders &
their functionality
Lead optimization
~6-9 Months
PoC Studies
Pharmacology
PK/PD
nGLP TOX in
Rodents & Cyno
~6-9 Months
GLP & IND
RCB
GLP Tox studies
IND enabling
studies
~12-18 Months
CMC
Cell banking &
Characterization
Clinical material
generation
IND enabling
studies
~12-18 Months
*Clinical trials
Phase-I, II, III & IV
Indication driven
*Clinical trial material supplies only
At Lextro Bio Solutions, we ensure that:
- The Target Product Profile needs are met as per the specifications while applying next-generation tools and technologies for lead and backup molecules identification and validation in in-vitro and in-vivo research
- Unique solutions for accelerated drug discovery and development are provided, by including translational studies early-on to increase the chances of clinical success
- The needs of the projects are met rapidly through a seamless blending of our therapeutic drug discovery competencies and our deep domain experience in the generation of GLP materials from both bacterial as well as mammalian cell cultures